Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. (2018)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2018.08.013
PubMed Identifier: 30253333
Publication URI: http://europepmc.org/abstract/MED/30253333
Type: Journal Article/Review
Volume: 103
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049